Back to Search
ALISON KAVANAUGH, MD
MD
Pediatrics Physician
NPI: 1467460428Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
2006-01031(NC)
Research & Publications (20)
Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
PMID 19147616·Ann Rheum Dis·2010
4-observational
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry.
PMID 19359261·Ann Rheum Dis·2010
4-observational
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial.
PMID 19015207·Ann Rheum Dis·2009
3-trial
Infection prophylaxis in antirheumatic therapy: emphasis on vaccination.
PMID 19444117·Curr Opin Rheumatol·2009
6-review
Perceptions of disease and health-related quality of life among patients with gout.
PMID 19307257·Rheumatology (Oxford)·2009
4-observational
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
PMID 19333948·Arthritis Rheum·2009
3-trial
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.
PMID 19217154·Lancet·2009
4-observational
A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.
PMID 19527820·J Am Acad Dermatol·2009
8-other
Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
PMID 19369454·J Rheumatol·2009
4-observational
The clinical efficacy of tocilizumab in rheumatoid arthritis.
PMID 19436841·Drugs Today (Barc)·2009
6-review
Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.
PMID 19333944·Arthritis Rheum·2009
3-trial
Treatment disparity related to race/ethnicity and education in rheumatoid arthritis patients: comment on the article by Constantinescu et al.
PMID 19644891·Arthritis Rheum·2009
8-other
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.
PMID 19209259·Ther Clin Risk Manag·2008
8-other
Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial.
PMID 18975322·Arthritis Rheum·2008
2-rct
The treatment of psoriatic arthritis and inflammatory spondylitis.
PMID 18973733·Curr Pain Headache Rep·2008
6-review
Evaluation of an instrument assessing influence of Gout on health-related quality of life.
PMID 18925685·J Rheumatol·2008
4-observational
Utilization of smoking cessation informational, interactive, and online community resources as predictors of abstinence: cohort study.
PMID 19103587·J Med Internet Res·2008
8-other
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.
PMID 19022808·Ann Rheum Dis·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7011 FAYETTEVILLE RD STE 210
DURHAM, NC 27713 - Phone
- (919) 806-3335
Quick Facts
- NPI
- 1467460428
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile